cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kalvista Pharmaceuticals Inc
1 own
10 watching
Current Price
$10.72
$-0.49
(-4.37%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
463.27M
52-Week High
52-Week High
16.88
52-Week Low
52-Week Low
7.21
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization463.27M
icon52-Week High16.88
icon52-Week Low7.21
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Kalvista Pharmaceuticals Inc do?
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company s product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which has completed Phase II clinical trial for an oral on-demand therapy for acute HAE attacks; and KVD824, an oral product candidate for the treatment of HAE. The company is headquartered in Cambridge, Massachusetts.
Read More
How much money does Kalvista Pharmaceuticals Inc make?
News & Events about Kalvista Pharmaceuticals Inc.
Business Wire
1 year ago
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced it will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare...
Business Wire
1 year ago
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors today announced that results from the phase 2 trial evaluating the efficacy and safety of oral sebetralstat...
Business Wire
1 year ago
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced it will be presenting at the SVB Securities Global Biopharma Conference (virtual) on...
Business Wire
1 year ago
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that it has entered into a subscription agreement with institutional investors to sell, in...
Zolmax
1 year ago
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV Get Rating) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 2,080,000 shares, a decrease of 8.8% from the October 31st total of 2,280,000 shares. Based on ...
Frequently Asked Questions
Frequently Asked Questions
What is Kalvista Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Kalvista Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Kalvista Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Kalvista Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kalvista Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Kalvista Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Kalvista Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kalvista Pharmaceuticals Inc?
plus_minus_icon
What percentage is Kalvista Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kalvista Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.72
$-0.49
(-4.37%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PHATHOM PHARMACEUTICALS INC
PHATHOM PHARMACEUTICALS INC
$18.70
$0.79 (4.41 %)
Avid Bioservices Inc
Avid Bioservices Inc
$10.60
$0.11 (1.05 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$2.32
$0.03 (1.31 %)
Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc.
$13.27
$-0.13 (-0.97 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
PHATHOM PHARMACEUTICALS INC
PHATHOM PHARMACEUTICALS INC
$18.70
$0.79 (4.41 %)
Avid Bioservices Inc
Avid Bioservices Inc
$10.60
$0.11 (1.05 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$2.32
$0.03 (1.31 %)
Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc.
$13.27
$-0.13 (-0.97 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00